International cannabis company IM Cannabis (IMC) reported a significant rise in its revenue for the whole of 2022 as well as the last quarter of the year
Canadian cannabis producer Cronos Group saw overall reduced losses for the year, with results helped by sales growth in Canada and Israel but hindered by lower sales in the US
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
Israeli cannabis firm InterCure is collaborating with US brand Cookies to launch Europe’s first flagship Cookies store in Vienna; meanwhile, Panaxia Labs exports to Germany from Malta
Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis
Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids
Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting from HIV
Texas-based Collective Growth is remaining positive despite failing to find the right partners for a $150m investment fund raised to develop the US hemp market
Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products
Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products
Some recent research has cast doubt on the idea that cannabis compounds may be more effective when taken together
Firms from Israel and South America are showing faith in the European CBD market, and its bricks-and-mortar retail, with distribution deals to place their products in a growing number of outlets
Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal
Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest celebrity to endorse CBD, plus more
Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more
Two new studies have shown hopeful signs that CBD could be combined with existing drugs to improve treatment – in one case, of cancer, and in the other of the potentially deadly E. coli
Researchers in Canada have for the first time revealed how CBD can block unwanted THC-related side-effects of cannabis. Also: Can CBD relieve anxiety disorders? and the therapeutic potential of ‘Turbo’ oil tested
CBD-Intel brings you business and related news in brief from the US, China, Israel and UK
Items from China, Thailand, Colombia, Israel, the US, Canada, UK and Ireland include news of the political leader’s son who is planning to open a hemp store, with dad’s blessing
Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight
CBD-Intel brings you up-to-date with the latest developments in the fast-moving world of CBD business deals
Elvis Presley CBD for your hound dog? CBD-Intel’s business news round-up includes items from New York, British Columbia, Ireland, the UK, Hong Kong, Israel, Australia and Colombia
A new partnership expands Israel’s global cannabis ties and gives a Chinese investor access to an entire portfolio of cannabis and hemp-related start-ups
Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Two CBD products have received kosher status from the largest agency in Europe dealing with rabbinically-approved foodstuffs.
London-based Advance Biotech received kosher certification from KLBD Kosher Certification in September 2018, followed by Provocan, a CBD brand made by Jerusalem-based company Ciitech, later in the year.
Because CBD oils are ingested orally, they require kosher certification.